EP 1208198 A2 20020529 - EGFH2 GENES AND GENE PRODUCTS
Title (en)
EGFH2 GENES AND GENE PRODUCTS
Title (de)
EGFH2 GENE UND GENPRODUKTE
Title (fr)
G NES EGFH2 ET PRODUITS G NIQUES
Publication
Application
Priority
- US 0022326 W 20000815
- US 14998699 P 19990820
Abstract (en)
[origin: WO0114415A2] This invention relates to mouse and human EGFH2, and to variants thereof and to polynucleotides encoding EGFH2. This invention also relates to therapeutic agents related to the polynucleotides and proteins.
IPC 1-7
C12N 15/12; C07K 14/475; C07K 16/22; C12Q 1/68; G01N 33/50; A61K 38/18
IPC 8 full level
C12N 15/09 (2006.01); A61K 9/48 (2006.01); A61K 31/711 (2006.01); A61K 35/12 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 9/10 (2006.01); A61P 17/02 (2006.01); A61P 19/08 (2006.01); A61P 21/04 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07K 14/475 (2006.01); C07K 14/485 (2006.01); C07K 16/22 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12P 21/02 (2006.01); C12Q 1/68 (2006.01)
CPC (source: EP)
A61P 9/10 (2017.12); A61P 17/02 (2017.12); A61P 19/08 (2017.12); A61P 21/04 (2017.12); A61P 25/00 (2017.12); A61P 25/08 (2017.12); A61P 25/14 (2017.12); A61P 25/16 (2017.12); A61P 25/28 (2017.12); A61P 31/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07K 14/4756 (2013.01); A61K 38/00 (2013.01)
Citation (search report)
See references of WO 0114415A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0114415 A2 20010301; WO 0114415 A3 20010726; AU 6773200 A 20010319; EP 1208198 A2 20020529; JP 2003510029 A 20030318
DOCDB simple family (application)
US 0022326 W 20000815; AU 6773200 A 20000815; EP 00955542 A 20000815; JP 2001518744 A 20000815